|
In May 1978, 3M informed Du Pont of the presence of organic fluorocompounds, including PFOA, in the blood of employees exposed to fluorosurfactants, prompting Chambers Works to initiate a program to assess exposure levels and health effects, which found that while employee blood levels were slightly elevated compared to a control group, they remained below 1 ppm and no adverse
|
— |
AR226-3467
|
e1vkQBeeJgjd35qNz9m6M5Q74 |
3 |